LAENNEC

Human placenta hydrolysate · Green Cross Wellbeing

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LAENNEC, covering 2026-02-23 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop [Phase 3]

See pricing